Related Experiment Video

Updated: Jul 18, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Expression and effect of adrenomedullin in pheochromocytoma

Zheng-Pei Zeng1, Dong-Mei Liu, Han-Zhong Li

  • 1Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China. zengzhengpei@yahoo.com.cn

Annals of the New York Academy of Sciences
|November 15, 2006
PubMed

Insights

Human adrenomedullin (ADM) and its receptor (RAMP2/CRLR) mRNA are highly expressed in pheochromocytoma. ADM was found to inhibit pheochromocytoma cell proliferation, suggesting a local regulatory role.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Pheochromocytoma is a neuroendocrine tumor arising from chromaffin cells of the adrenal medulla.
  • Adrenomedullin (ADM) is a peptide hormone with diverse physiological roles, including potential involvement in tumor growth.
  • The ADM receptor complex consists of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying protein 2 (RAMP2).

Purpose of the Study:

  • To investigate the expression of ADM and its receptor components (RAMP2/CRLR) mRNA in pheochromocytoma.
  • To determine the effect of ADM on the proliferation of human pheochromocytoma cells.

Main Methods:

  • Reverse transcriptase polymerase chain reaction (RT-PCR) was used to analyze mRNA expression levels.
  • 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was employed to assess cell proliferation.

Main Results:

  • ADM, RAMP2, and CRLR mRNA were detected in both normal adrenal medulla and pheochromocytoma tissues.
  • Significantly higher mRNA expression levels of ADM, RAMP2, and CRLR were observed in pheochromocytomas compared to normal adrenal medulla.
  • ADM demonstrated an inhibitory effect on the proliferation of human pheochromocytoma cells.

Conclusions:

  • Pheochromocytomas exhibit elevated expression of ADM and its receptor components (RAMP2/CRLR).
  • ADM may play an autocrine or paracrine role in regulating pheochromocytoma cell proliferation within the adrenal gland.

More Related Videos

Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis08:08

Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis

Published on: February 19, 2018

Mouse Adrenal Chromaffin Cell Isolation18:30

Mouse Adrenal Chromaffin Cell Isolation

Published on: January 5, 2007

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...